Atlas Trials

Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®

Clinical trial NCT05230550 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05230550
Sponsor
Novo Nordisk A/S
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Adult Growth Hormone Deficiency
Start date
2022-02-03
Primary completion
2026-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.